A comparison of flag-ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the uk ncri aml17 trial

HIGHLIGHTS

• who: A K Burnett from the clofarabine in high-risk leukaemia: data from the UK have published the article: A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial, in the Journal: (JOURNAL) of 26/09/2017

SUMMARY

For them the best approach is a myeloablative allogeneic transplant; however, even the transplant option provides only a 30% chance of cure, and has been limited to younger patients who have a donor. Better treatment could deliver more patients to transplant who . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.